Abstract
Allogeneic hematopoietic cell transplantation (alloHCT) survivors have been recently recognized as patients at increased cardiovascular risk. We hypothesized that vascular function remains impaired in alloHCT survivors free of graft-versus-host-disease or relapse. We enrolled consecutive adult alloHCT survivors and non-HCT control individuals (January 2019–March 2020), matched for traditional cardiovascular risk factors. Microvascular dysfunction was dynamically assessed in real time by Laser Speckle Contrast Analysis (LASCA). Carotid-femoral pulse-wave velocity (PWV) and carotid intima media thickness (IMT) were assessed as surrogate markers of cardiovascular disease. We studied 75 patients after a median of 3.2 (range 2.1–4.9) years from alloHCT, who had suffered from grade 2 to 3 acute (20%) and/or moderate/severe chronic GVHD (42%), and 75 controls. Although traditional cardiovascular risk factors and surrogate markers of cardiovascular disease did not differ between groups, alloHCT survivors showed significantly impaired microvascular function (baseline and peak flux, time to peak, base to peak and base to occlusion change). LASCA indices were also independently associated with alloHCT. Our study shows for the first-time impaired microcirculation dynamics in alloHCT survivors, independently of cardiovascular risk factors. Additional studies are needed to address the role of novel markers in cardiovascular risk prediction, along with effects of disease type, phase, and pre-transplant treatments.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gratwohl A, Pasquini MC, Aljurf M, Atsuta Y, Baldomero H, Foeken L, et al. One million haemopoietic stem-cell transplants: a retrospective observational study. Lancet Haematol. 2015;2:e91–100. https://doi.org/10.1016/S2352-3026(15)00028-9. e-pub ahead of print 2015/12/22.
Chow EJ, Wong K, Lee SJ, Cushing-Haugen KL, Flowers ME, Friedman DL, et al. Late cardiovascular complications after hematopoietic cell transplantation. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2014;20:794–800. https://doi.org/10.1016/j.bbmt.2014.02.012. e-pub ahead of print 2014/02/26.
Bhatia S, Francisco L, Carter A, Sun CL, Baker KS, Gurney JG, et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood. 2007;110:3784–3792. https://doi.org/10.1182/blood-2007-03-082933. e-pub ahead of print 2007/08/03.
Baker KS, Chow E, Steinberger J. Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation. Bone Marrow Transplant. 2012;47:619–625. https://doi.org/10.1038/bmt.2011.118. e-pub ahead of print 2011/06/07.
Gavriilaki E, Gkaliagkousi E, Grigoriadis S, Anyfanti P, Douma S, Anagnostopoulos A. Hypertension in hematologic malignancies and hematopoietic cell transplantation: an emerging issue with the introduction of novel treatments. Blood Rev. 2019. e-pub ahead of print 2019/03/23; https://doi.org/10.1016/j.blre.2019.03.003.
Gavriilaki E, Gkaliagkousi E, Sakellari I, Anyfanti P, Douma S, Anagnostopoulos A. Early Prediction of Cardiovascular Risk after Hematopoietic Cell Transplantation: are we there yet. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2019;25:e310–e316. https://doi.org/10.1016/j.bbmt.2019.07.012. e-pub ahead of print 2019/07/17.
Triantafyllou A, Anyfanti P, Zabulis X, Gavriilaki E, Karamaounas P, Gkaliagkousi E, et al. Accumulation of microvascular target organ damage in newly diagnosed hypertensive patients. J Am Soc Hypertension. 2014;8:542–549. https://doi.org/10.1016/j.jash.2014.04.008. e-pub ahead of print 2014/06/11.
Dipla K, Triantafyllou A, Grigoriadou I, Kintiraki E, Triantafyllou GA, Poulios P, et al. Impairments in microvascular function and skeletal muscle oxygenation in women with gestational diabetes mellitus: links to cardiovascular disease risk factors. Diabetologia. 2017;60:192–201. https://doi.org/10.1007/s00125-016-4129-7. e-pub ahead of print 2016/10/11.
Mahe G, Humeau-Heurtier A, Durand S, Leftheriotis G, Abraham P. Assessment of skin microvascular function and dysfunction with laser speckle contrast imaging. Circ Cardiovasc Imaging. 2012;5:155–63. https://doi.org/10.1161/CIRCIMAGING.111.970418. e-pub ahead of print 2012/01/19.
Roustit M, Cracowski JL. Assessment of endothelial and neurovascular function in human skin microcirculation. Trends Pharmacol Sci. 2013;34:373–84. https://doi.org/10.1016/j.tips.2013.05.007. e-pub ahead of print 2013/06/25.
Humeau-Heurtier A, Abraham P, Mahe G. Analysis of laser speckle contrast images variability using a novel empirical mode decomposition: comparison of results with laser Doppler flowmetry signals variability. IEEE Trans Med Imaging. 2015;34:618–27. https://doi.org/10.1109/TMI.2014.2364079. e-pub ahead of print 2014/10/28.
Ruaro B, Sulli A, Alessandri E, Pizzorni C, Ferrari G, Cutolo M. Laser speckle contrast analysis: a new method to evaluate peripheral blood perfusion in systemic sclerosis patients. Ann Rheum Dis. 2014;73:1181–85. https://doi.org/10.1136/annrheumdis-2013-203514. e-pub ahead of print 2013/08/21.
Ruaro B, Smith V, Sulli A, Pizzorni C, Tardito S, Patane M, et al. Innovations in the Assessment of Primary and Secondary Raynaud’s Phenomenon. Front Pharmacol. 2019;10:360 https://doi.org/10.3389/fphar.2019.00360. e-pub ahead of print 2019/05/11.
Koletsos N, Gkaliagkousi E, Lazaridis A, Triantafyllou A, Anyfanti P, Dolgyras P, et al. Skin microvascular dysfunction in systemic lupus erythematosus patients with and without cardiovascular risk factors. Rheumatology (Oxford). 2020. e-pub ahead of print 2021/01/01; https://doi.org/10.1093/rheumatology/keaa722.
Souza EG, De Lorenzo A, Huguenin G, Oliveira GM, Tibirica E. Impairment of systemic microvascular endothelial and smooth muscle function in individuals with early-onset coronary artery disease: studies with laser speckle contrast imaging. Coron Artery Dis. 2014;25:23–8. https://doi.org/10.1097/MCA.0000000000000055. e-pub ahead of print 2013/11/01.
Lazaridis A, Gkaliagkousi E, Koletsos N, Nikolaidou B, Anyfanti P, Dolgyras P, et al. Association of endothelial dysfunction in microcirculation using laser speckle contrast analysis with markers of arterial stiffness. J Hypertens. 2018;36:e99–e100. https://doi.org/10.1097/01.hjh.0000539257.96723.2d.
Vuilleumier P, Decosterd D, Maillard M, Burnier M, Hayoz D. Postischemic forearm skin reactive hyperemia is related to cardovascular risk factors in a healthy female population. J Hypertens. 2002;20:1753–1757. https://doi.org/10.1097/00004872-200209000-00018. e-pub ahead of print 2002/08/27.
Khalil A, Humeau-Heurtier A, Mahe G, Abraham P. Laser speckle contrast imaging: age-related changes in microvascular blood flow and correlation with pulse-wave velocity in healthy subjects. J Biomed Opt. 2015;20:051010. https://doi.org/10.1117/1.JBO.20.5.051010. e-pub ahead of print 2014/11/26.
Sakellari I, Batsis I, Bousiou Z, Mallouri D, Constantinou V, Gavriilaki E, et al. The Role of Low-dose Anti-thymocyte Globulin as Standard Prophylaxis in Mismatched and Matched Unrelated Hematopoietic Peripheral Stem Cell Transplantation for Hematologic Malignancies. Clin Lymphoma Myeloma Leuk. 2017;17:658–66. https://doi.org/10.1016/j.clml.2017.06.008. e-pub ahead of print 2017/07/19.
Lee SJ, Wolff D, Kitko C, Koreth J, Inamoto Y, Jagasia M, et al. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2015;21:984–99. https://doi.org/10.1016/j.bbmt.2015.02.025. e-pub ahead of print 2015/03/23.
Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995;15:825–28. e-pub ahead of print 1995/06/01.
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Blood Press. 2018;27:314–40. https://doi.org/10.1080/08037051.2018.1527177. e-pub ahead of print 2018/11/02.
Gkaliagkousi E, Gavriilaki E, Nikolaidou B, Triantafyllou G, Douma S. Exercise-induced pulse wave velocity changes in untreated patients with essential hypertension: the effect of an angiotensin receptor antagonist. J Clin Hypertens (Greenwich). 2014;16:482–87. https://doi.org/10.1111/jch.12340. e-pub ahead of print 2014/05/24.
Roustit M, Cracowski JL. Non-invasive assessment of skin microvascular function in humans: an insight into methods. Microcirculation. 2012;19:47–64. https://doi.org/10.1111/j.1549-8719.2011.00129.x. e-pub ahead of print 2011/09/03.
Rousseau P, Mahe G, Haj-Yassin F, Durand S, Humeau A, Leftheriotis G, et al. Increasing the “region of interest” and “time of interest”, both reduce the variability of blood flow measurements using laser speckle contrast imaging. Microvasc Res. 2011;82:88–91. https://doi.org/10.1016/j.mvr.2011.03.009. e-pub ahead of print 2011/03/29.
Luft T, Benner A, Jodele S, Dandoy CE, Storb R, Gooley T, et al. EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis. Lancet Haematol. 2017;4:e414–e423. https://doi.org/10.1016/S2352-3026(17)30108-4. e-pub ahead of print 2017/07/25.
Pao E, Gove NE, Flynn JT, Hingorani S. Ambulatory Blood Pressure and Endothelial Dysfunction in Hematopoietic Cell Transplantation Recipients. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2018;24:1678–84. https://doi.org/10.1016/j.bbmt.2018.04.024. e-pub ahead of print 2018/04/29.
Suresh K, Chandrashekara S. Sample size estimation and power analysis for clinical research studies. J Hum Reprod Sci. 2012;5:7–13. https://doi.org/10.4103/0974-1208.97779. e-pub ahead of print 2012/08/08.
Luft T, Wendtner CM, Kosely F, Radujkovic A, Benner A, Korell F, et al. EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients. Front Immunol. 2021;12:634416 https://doi.org/10.3389/fimmu.2021.634416. e-pub ahead of print 2021/07/13.
Tibirica E, Rodrigues E, Cobas R, Gomes MB. Impairment of skin capillary recruitment precedes chronic complications in patients with type 1 diabetes. Rev Diabet Stud. 2007;4:85–8. https://doi.org/10.1900/RDS.2007.4.85. e-pub ahead of print 2007/09/08.
Biedermann BC, Sahner S, Gregor M, Tsakiris DA, Jeanneret C, Pober JS, et al. Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease. Lancet. 2002;359:2078–83. https://doi.org/10.1016/S0140-6736(02)08907-9. e-pub ahead of print 2002/06/28.
Biedermann BC, Tsakiris DA, Gregor M, Pober JS, Gratwohl A. Combining altered levels of effector transcripts in circulating T cells with a marker of endothelial injury is specific for active graft-versus-host disease. Bone Marrow Transplant. 2003;32:1077–84. https://doi.org/10.1038/sj.bmt.1704258. e-pub ahead of print 2003/11/20.
Roustit M, Millet C, Blaise S, Dufournet B, Cracowski JL. Excellent reproducibility of laser speckle contrast imaging to assess skin microvascular reactivity. Microvasc Res. 2010;80:505–11. https://doi.org/10.1016/j.mvr.2010.05.012. e-pub ahead of print 2010/06/15.
Poreba M, Gac P, Usnarska-Zubkiewicz L, Pilecki W, Kuliczkowski K, Mazur G, et al. Endothelial Function in Patients with Hematologic Malignancies Undergoing High-Dose Chemotherapy Followed by Hematopoietic Stem Cell Transplantation. Cardiovasc Toxicol. 2016;16:156–62. https://doi.org/10.1007/s12012-015-9324-0. e-pub ahead of print 2015/04/10.
Vatanen A, Sarkola T, Ojala TH, Turanlahti M, Jahnukainen T, Saarinen-Pihkala UM, et al. Radiotherapy-related arterial intima thickening and plaque formation in childhood cancer survivors detected with very-high resolution ultrasound during young adulthood. Pediatr Blood Cancer. 2015;62:2000–6. https://doi.org/10.1002/pbc.25616. e-pub ahead of print 2015/06/09.
Dengel DR, Kelly AS, Zhang L, Wang Q, Hodges JS, Steinberger J, et al. Vascular Structure and Function in Cancer Survivors after Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2019;25:151–56. https://doi.org/10.1016/j.bbmt.2018.08.005. e-pub ahead of print 2018/08/14.
Gavriilaki E, Sakellari I, Anyfanti P, Batsis I, Vardi A, Bousiou Z, et al. Assessment of Endothelial Injury and Pro-Coagulant Activity Using Circulating Microvesicles in Survivors of Allogeneic Hematopoietic Cell Transplantation. Int J Mol Sci. 2020; 21. e-pub ahead of print 2020/12/30; https://doi.org/10.3390/ijms21249768.
Gavriilaki E, Sakellari I, Chatzikonstantinou T, Mallouri D, Batsis I, Vardi A, et al. Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell Transplantation. Hemasphere. 2021;5:e487 https://doi.org/10.1097/HS9.0000000000000487. e-pub ahead of print 2020/12/17.
Venturi E, Pinnola S, Morizzo C, Boldrini B, Rossi M, Trifiro S, et al. Clinical Phenotype and Microvascular Dynamics of Subjects with Endothelial Dysfunction as Assessed by Peripheral Tonometry. Microcirculation. 2016;23:230–9. https://doi.org/10.1111/micc.12268. e-pub ahead of print 2016/01/23.
Funding
This research is co-financed by Greece and the European Union (European Social Fund- ESF) through the Operational Programme “Human Resources Development, Education and Lifelong Learning 2014–2020” in the context of the project “Evaluation of novel markers of endothelial dysfunction and thrombotic microenvironment in patients with rheumatoid arthritis: association with markers of subclinical inflammation and cardiovascular damage (MIS 5047870)”. EG is also supported by the ASH Global Research Award.
Author information
Authors and Affiliations
Contributions
Conceptualization, ELG and EG; Methodology, IS, PA, BN, MG; Software, AL, NK; Validation, IZ and MM; Formal analysis, ELG and PA; Investigation, IB, AV, and ZB; Resources, SD; Writing—original draft preparation, ELG; Writing—review and editing, EG, IS, AA; Supervision, SD and AA; Funding acquisition, EG and AP. All authors have read and agreed to the published version of the paper.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Gavriilaki, E., Anyfanti, P., Sakellari, I. et al. A non-interventional study of microcirculation dynamics in allogeneic hematopoietic cell transplantation survivors compared to controls: evidence of impaired microvascular response regardless of conventional cardiovascular risk factors. Bone Marrow Transplant 57, 72–77 (2022). https://doi.org/10.1038/s41409-021-01500-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41409-021-01500-w